香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 江西一脈陽光集團股份有限公司 董事長、執行董事兼行政總裁 陳朝陽先生 香港，2025年8月6日 於本公告日期，董事會包括執行董事陳朝陽先生、何英飛女士、馮勰先生及李飛 宇先生；非執行董事劉森林先生及郭濤先生；及獨立非執行董事吳曉輝先生、羅 毅先生及陳伊菲女士。 （股份代號：2522） 董事會會議日期 江西一脈陽光集團股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈，董事 會會議將於2025年8月18日（星期一）舉行，藉以（其中包括）考慮及批准本公司及 其附屬公司截至2025年6月30日止六個月之中期業績及其發佈，並考慮建議派發 中期股息（如有）。 承董事會命 （於中華人民共和國註冊成立的股份有限公司） ...

Core Viewpoint - The company Yipai Yangguang (02522) has experienced a significant stock price increase of over 5%, currently trading at 15.88 HKD with a transaction volume of 768 million HKD, following the announcement of a positive earnings forecast for the first half of the year [1] Financial Performance - The company expects revenue for the first half of the year to be between 450 million to 480 million RMB, representing a year-on-year growth of approximately 8.77% to 16.03% [1] - The projected net profit is estimated to be between 14.5 million to 16.5 million RMB, indicating a substantial year-on-year increase of approximately 1350% to 1550% [1] Factors Influencing Performance - The increase in revenue is attributed to a rise in the number of customers and the services delivered by the company [1] - The significant growth in net profit is primarily due to the increase in revenue compared to the same period in 2024 and a reduction in administrative expenses [1]

消息面上，一脉阳光日前发盈喜，预计上半年收入4.5亿至4.8亿元人民币，同比增长约8.77%至 16.03%；纯利1450万元至1650万元人民币，同比增长约1350%至1550%。董事会认为，收入增加主要是 由于公司的客户数目及所交付的服务数目增加，纯利增加乃主要由于上述于有关期间的收入较2024年同 期增加及行政开支的减少。 智通财经APP获悉，一脉阳光(02522)再涨超5%，截至发稿，涨5.51%，报15.88港元，成交额7.68亿港 元。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 本月底法定/註冊股本總額： RMB 366,061,832 FF301 第 1 頁 共 10 頁 v 1.1.1 致：香港交易及結算所有限公司 公司名稱: 江西一脈陽光集團股份有限公司 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02522 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 259,128,074 | RMB | | 1 RMB | | 259,128,074 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 259,128,074 | RMB | | 1 ...

Group 1 - Xindong Company (02400) reported a positive earnings forecast, expecting revenue of at least RMB 3.05 billion for the first half of 2025, a year-on-year increase of approximately 37%, and a net profit of at least RMB 790 million, a year-on-year increase of about 215% [1] - Yimai Sunshine (02522) also announced a positive earnings forecast, expecting revenue between RMB 450 million to 480 million for the first half of the year, a year-on-year increase of approximately 8.77% to 16.03%, and a net profit of RMB 14.5 million to 16.5 million, a year-on-year increase of about 1350% to 1550% [1] - Tianli International Holdings (01773) plans to repurchase shares up to a total of HKD 200 million based on market conditions, believing that the share buyback plan is in the best interest of the company and its shareholders [2] Group 2 - Liaogang Co., Ltd. (02880) reported a total operating revenue of RMB 5.693 billion for the first half of 2025, a year-on-year increase of 5.93%, and a net profit attributable to shareholders of RMB 956 million, a year-on-year increase of 110.78% [2] - Yuan Zheng Technology (02488) reported a revenue of RMB 982 million for the first half of 2025, a year-on-year increase of 9.75%, and a net profit of RMB 195 million, a year-on-year increase of 27.74% [2] - Geekplus Technology (02590) expects revenue between RMB 995 million to 1.03 billion for the first half of the year, a year-on-year increase of 27% to 32%, while the net loss is expected to narrow significantly [3] Group 3 - Lee & Man Paper Manufacturing (02314) and other leading companies in the paper industry have initiated a price increase for various products starting August 1, indicating a significant acceleration in price adjustment frequency within the industry [3] - Xinda Biopharmaceutical (01801) announced that its innovative oral small molecule GLP-1R agonist IBI3032 has received IND approval from the FDA [4] - Heyu-B (02256) reported a revenue of RMB 612 million for the first half of the year, a year-on-year increase of 23.1%, and a net profit of RMB 328 million, a year-on-year increase of 58.84% [4] Group 4 - Bilibili (BILI.US) is expected to achieve a revenue growth of 20% year-on-year to RMB 7.3 billion in the second quarter, driven by stable performance in mobile games [5][6] - Li Auto (LI.US) launched the Li Xiang i8, with deliveries starting on August 20, and received positive outlooks from multiple institutions [6] - Xpeng Motors (XPEV.US) achieved a new monthly delivery record in July, delivering 36,717 smart electric vehicles, a year-on-year increase of 229% [7]

消息面上，一脉阳光发布盈喜，预计上半年收入4.5亿至4.8亿元人民币，同比增长约8.77%至16.03%； 纯利1450万元至1650万元人民币，同比增长约1350%至1550%。董事会认为，收入增加主要是由于公司 的客户数目及所交付的服务数目增加，纯利增加乃主要由于上述于有关期间的收入较2024年同期增加及 行政开支的减少。 值得注意的是，一脉阳光近期发布公告，公司董事会已审议及批准公司若干股东所持公司1.04亿股未上 市股份(占公司于本公告日期已发行股本总额的约28.46%)拟实施全流通。于本公告日期，H股全流通仍 有待取得所有相关批准(包括中国证监会的备案通知)、将该等未上市股份转换为公司H股及香港联合交 易所有限公司批准该等H股于联交所主板上市及买卖。 智通财经获悉，一脉阳光(02522)高开逾7%，截至发稿，涨7.49%，报14.49港元，成交额1266.43万港 元。 本文源自智通财经网 ...

值得注意的是，一脉阳光近期发布公告，公司董事会已审议及批准公司若干股东所持公司1.04亿股未上 市股份(占公司于本公告日期已发行股本总额的约28.46%)拟实施全流通。于本公告日期，H股全流通仍 有待取得所有相关批准(包括中国证监会的备案通知)、将该等未上市股份转换为公司H股及香港联合交 易所有限公司批准该等H股于联交所主板上市及买卖。 智通财经APP获悉，一脉阳光(02522)高开逾7%，截至发稿，涨7.49%，报14.49港元，成交额1266.43万 港元。 消息面上，一脉阳光发布盈喜，预计上半年收入4.5亿至4.8亿元人民币，同比增长约8.77%至16.03%； 纯利1450万元至1650万元人民币，同比增长约1350%至1550%。董事会认为，收入增加主要是由于公司 的客户数目及所交付的服务数目增加，纯利增加乃主要由于上述于有关期间的收入较2024年同期增加及 行政开支的减少。 ...

Core Viewpoint - The company, Yimai Sunshine (02522), has announced a positive earnings forecast, leading to a significant increase in its stock price, reflecting strong revenue and profit growth expectations for the first half of the year [1] Financial Performance - The company expects revenue for the first half of the year to be between 450 million to 480 million RMB, representing a year-on-year growth of approximately 8.77% to 16.03% [1] - Projected net profit is estimated to be between 14.5 million to 16.5 million RMB, indicating a substantial year-on-year increase of approximately 1350% to 1550% [1] - The increase in revenue is attributed to a rise in the number of customers and services delivered, while the profit increase is mainly due to higher revenue compared to the same period in 2024 and a reduction in administrative expenses [1] Shareholder Actions - The company's board has approved the full circulation of 104 million unlisted shares held by certain shareholders, which accounts for approximately 28.46% of the total issued share capital as of the announcement date [1] - The full circulation of H-shares is pending approval from relevant authorities, including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [1]

Core Viewpoint - The company anticipates a significant increase in revenue and net profit for the six months ending June 30, 2025, compared to the same period in 2024, driven by an increase in customer numbers and services delivered [1] Revenue Summary - The company expects revenue to be between approximately RMB 450 million and RMB 480 million for the six months ending June 30, 2025, compared to approximately RMB 413.7 million for the same period in 2024, representing a year-on-year growth of approximately 8.77% to 16.03% [1] Net Profit Summary - The anticipated net profit for the six months ending June 30, 2025, is expected to be between approximately RMB 14.5 million and RMB 16.5 million, a substantial increase from approximately RMB 1 million for the same period in 2024, indicating a year-on-year growth of approximately 1350% to 1550% [1] Factors Contributing to Growth - The board attributes the increase in revenue compared to 2024 to a rise in the number of customers and services delivered, while the significant increase in net profit is primarily due to the rise in revenue and a reduction in administrative expenses [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2522） 於本公告日期，本公司仍在審定本集團於有關期間的中期業績。本公告所載資料 僅基於本公司管理層參照本集團於有關期間的未經審核管理賬目及董事會現時可 獲得的資料而作出的初步評估，該等資料並未經本公司核數師或審計委員會審核 或審閱。本集團有關期間的實際業績可能與本公告所披露者存在差異。根據上市 規則，本集團於有關期間的中期業績公告預期於2025年8月31日或之前公佈。 本公司股東及潛在投資者於買賣本公司股份時務請審慎行事。 承董事會命 正面盈利預告 本公告乃江西一脈陽光集團股份有限公司（「本公司」，連同其附屬公司，「本集 團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)條及證 券及期貨條例（香港法例第571章）第XIVA部項下 ...